
In what comes as a shocking development, it has been observed that deadly superbugs are on the rise in newborn babies. According to a new study, these so-called superbugs can be alarmingly prevalent in newborn babies,
to the point that frontline treatments for sepsis are no longer effective against the majority of these bacterial infections. Researchers focused on Southeast Asia (countries including Sri Lanka, Indonesia, Malaysia, Vietnam And the Philippines) for the new study, as they analyzed nearly 15,000 blood samples which were collected from sick infants at 10 hospitals across five regional countries in 2019 and 2020.Most infections involved Gram-negative bacteria, including E. coli, Klebsiella and Acinetobacter - which accounted for nearly 80% of cases. Many of these bacteria were non-susceptible to the first-line antibiotics recommended by the WHO. Antimicrobial resistance (AMR) was ominously common among disease-causing bacteria, says study co-author Phoebe Williams, a pediatrician at the University of Sydney. "Our study highlights the causes of serious infections in babies in countries across Southeast Asia with high rates of neonatal sepsis, and reveals an alarming burden of AMR that renders many currently available therapies ineffective for newborns," Williams says."Guidelines must be updated to reflect local bacterial profiles and known resistance patterns," she informed further.